What is NDC 68788-4187?

68788-4187 is the product NDC for Pioglitazone, Pioglitazone hydrochloride 30 mg/1 tablet, listed with the FDA by Preferred Pharmaceuticals Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.

Preferred Pharmaceuticals Inc., NDC labeler code 68788. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Pioglitazone?

43 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Pioglitazone NDC 68788-4187 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68788-4187Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68788-4187Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
68788-4187-1	6878841870168788418701	100 TABLET in 1 BOTTLE (68788-4187-1)Marketed from Aug 27, 2026
68788-4187-3	6878841870368788418703	30 TABLET in 1 BOTTLE (68788-4187-3)Marketed from Aug 27, 2026
68788-4187-6	6878841870668788418706	60 TABLET in 1 BOTTLE (68788-4187-6)Marketed from Aug 27, 2026
68788-4187-9	6878841870968788418709	90 TABLET in 1 BOTTLE (68788-4187-9)Marketed from Aug 27, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pioglitazone
Generic name (nonproprietary): pioglitazone
Active ingredients: Pioglitazone hydrochloride — 30 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Preferred Pharmaceuticals Inc.NDC labeler code 68788
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202467
Marketing start: Aug 27, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Peroxisome Proliferator-activated Receptor alpha Agonists (Mechanism)Peroxisome Proliferator-activated Receptor gamma Agonists (Mechanism)Thiazolidinediones (Chemical structure)
Identifiers: Product ID 68788-4187_c748f901-8321-4dc2-8848-b7ed27f11f97SPL ID c748f901-8321-4dc2-8848-b7ed27f11f97SPL set ID c748f901-8321-4dc2-8848-b7ed27f11f97RxCUI 312440UNII JQT35NPK6C
Pharmacologic class: Peroxisome Proliferator Receptor alpha Agonist; Peroxisome Proliferator Receptor gamma Agonist; Thiazolidinedione

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468788418701 followed by a unit qualifier and the quantity

Package 68788-4187-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 27, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Monotherapy and Combination Therapy Pioglitazone tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings [see Clinical Studies ( 14 ) ] . Important Limitations of Use Pioglitazone tablets, USP exerts its antihyperglycemic effect only in the presence of endogenous insulin. Pioglitazone tablets USP should not be used to treat type 1 diabetes or diabetic ketoacidosis, as it would not be effective in these settings. Use caution in patients with liver disease [see Warnings and Precautions ( 5.3 ) ]. Pioglitazone hydrochloride is a thiazolidinedione and an agonist for peroxisome proliferator-activate…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68788-4187

What is NDC 68788-4187?: 68788-4187 is the product NDC for Pioglitazone, Pioglitazone hydrochloride 30 mg/1 tablet, listed with the FDA by Preferred Pharmaceuticals Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Pioglitazone.
What is the active ingredient?: Pioglitazone hydrochloride.
Who is the labeler?: Preferred Pharmaceuticals Inc., NDC labeler code 68788. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Pioglitazone?: 43 other product NDCs are listed under this name. See all Pioglitazone NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Pioglitazone NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	American Health Packaging	60687-905	60687-0905-21
Pioglitazone	Pioglitazone hydrochloride 15 mg/1	TabletOral	AvKARE	42291-959	42291-0959-3042291-0959-90
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	AvKARE	42291-960	42291-0960-3042291-0960-90
Pioglitazone	Pioglitazone hydrochloride 45 mg/1	TabletOral	AvKARE	42291-961	42291-0961-3042291-0961-50
Pioglitazone	Pioglitazone hydrochloride 15 mg/1	TabletOral	NorthStar RxLLC	16714-645	16714-0645-0116714-0645-0216714-0645-03
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	NorthStar RxLLC	16714-646	16714-0646-0116714-0646-0216714-0646-03
Pioglitazone	Pioglitazone hydrochloride 45 mg/1	TabletOral	NorthStar RxLLC	16714-647	16714-0647-0116714-0647-0216714-0647-03
Pioglitazone	Pioglitazone hydrochloride 45 mg/1	TabletOral	A-S Medication Solutions	50090-6412	50090-6412-0050090-6412-01
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	A-S Medication Solutions	50090-6873	50090-6873-0050090-6873-01
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	A-S Medication Solutions	50090-6874	50090-6874-00

All 44 Pioglitazone NDCs

Other NDCs under ANDA 202467

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202467
Product	Strength	Form · route	Labeler	Product NDC
Pioglitazone	Pioglitazone hydrochloride 45 mg/1	TabletOral	A-S Medication Solutions	50090-6412
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-2264
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	A-S Medication Solutions	50090-6873
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	A-S Medication Solutions	50090-6874
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	Macleods Pharmaceuticals Limited	33342-055
Pioglitazone	Pioglitazone hydrochloride 15 mg/1	TabletOral	Macleods Pharmaceuticals Limited	33342-054
Pioglitazone	Pioglitazone hydrochloride 45 mg/1	TabletOral	Macleods Pharmaceuticals Limited	33342-056
Pioglitazone	Pioglitazone hydrochloride 30 mg/1	TabletOral	NorthStar RxLLC	16714-646
Pioglitazone	Pioglitazone hydrochloride 15 mg/1	TabletOral	NorthStar RxLLC	16714-645
Pioglitazone	Pioglitazone hydrochloride 45 mg/1	TabletOral	NorthStar RxLLC	16714-647